Table of Contents

company-logo

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Edgewise Therapeutics Dividend Announcement

• Edgewise Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Edgewise Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Edgewise Therapeutics Dividend History

Edgewise Therapeutics Dividend Yield

Edgewise Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Edgewise Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Edgewise Therapeutics Financial Ratios

P/E ratio-24.14
PEG ratio0.05
P/B ratio6.14
ROE-26.83%
Payout ratio0.00%
Current ratio26.35
Quick ratio26.35
Cash Ratio2.36

Edgewise Therapeutics Dividend FAQ

Does Edgewise Therapeutics stock pay dividends?
Edgewise Therapeutics does not currently pay dividends to its shareholders.
Has Edgewise Therapeutics ever paid a dividend?
No, Edgewise Therapeutics has no a history of paying dividends to its shareholders. Edgewise Therapeutics is not known for its dividend payments.
Why doesn't Edgewise Therapeutics pay dividends?
There are several potential reasons why Edgewise Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Edgewise Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Edgewise Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Edgewise Therapeutics a dividend aristocrat?
Edgewise Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Edgewise Therapeutics a dividend king?
Edgewise Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Edgewise Therapeutics a dividend stock?
No, Edgewise Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Edgewise Therapeutics stocks?
To buy Edgewise Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Edgewise Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.